References

  1. Kiss E, Bhattoa HP, Bettembuk P et al. Pregnancy in women with systemic lupus erythematosus. Eur J Obstet Gynecol Reprod Biol. 2002;101(2):129-34. PubMed | Google Scholar

  2. Smyth A, Oliveira GH, Lahr BD et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060-2068. PubMed | Google Scholar

  3. Miguel A,Saavedra S, Antonio BC et al. Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Reumatol Clin.2015;11(5):295-304. PubMed | Google Scholar

  4. Laskin CA,Spitzer KA, Clark CA et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled hepasa trial. J Rheumatol. 2009;36(2):279-287. PubMed | Google Scholar

  5. Jing Xiao, Jing Xiong, Fufan Zhu. Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome. Exp Ther Med. 2013; 5(1):287-291. PubMed | Google Scholar

  6. De Man YA,Dolhain RJ, van De Geijn FE et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241-8. PubMed | Google Scholar

  7. Bukhari M,Lunt M, Harrison BJ et al. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum. 2002;46(4):906-12. PubMed | Google Scholar

  8. Man YA, Hazes JM, vandeGeijn FE et al. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57(5):716-22. PubMed | Google Scholar

  9. Depaz R, Aboab J, Gout O.Update on diagnosis and treatment of multiple sclerosis. Rev Med Interne. 2013;34(10):628-35. PubMed | Google Scholar

  10. El-Etr M, Vukusic S, Gignoux Let al. Steroid hormones in multiple sclerosis. J Neurol Sci. 2005;233(2):49-54. PubMed | Google Scholar

  11. Schumacher M1, Guennoun R, Stein DG et al. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther. 2007;116(1):77-106. PubMed | Google Scholar

  12. Vukusic S,Ionescu I, El-Etr M et al. Prevention of post-partum relapses with progestin and estradiol in multiple sclerosis study group: the prevention of post-partum relapses with progestin and estradiol in multiple sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci. 2009;286(1):114-8. PubMed | Google Scholar

  13. Jadaon J,Shushan A, Ezra Y, et al. Behcet?s disease and pregnancy. Acta Obstet Gynecol Scand. 2005;84(10):939-944. PubMed | Google Scholar

  14. Hwang I, Lee CK, Yoo B et al. Necrotizing villitis and decidual vasculitis in the placentas of mothers with Behcet disease. Hum Pathol. 2009;40(1):135-138. PubMed | Google Scholar

  15. Hamuryudan V, Ozyazgan Y, Fresko Y et al. Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study. Isr Med Assoc J. 2002;4(11):928-30. PubMed | Google Scholar

  16. Saadoun D, Wechsler B, Terrada C et al. Azathioprine in severe uveitis of Behcet's disease. Arthritis Care Res (Hoboken). 2010;62(12):1733-8. PubMed | Google Scholar

  17. Steen VD. Pregnancy in scleroderma. Rheum Dis Clin North Am. 2007;33(2): 345-358. PubMed | Google Scholar

  18. Gore JE, Brown AN. Scleroderma renal crisis sine scleroderma in pregnancy: a case report. Clin Exp Rheumatol. 2006;24(1):87-8. PubMed | Google Scholar

  19. Cho KH, Heo SW,Chung SH et al. A case of mallory-weiss syndrome complicating pregnancy in a patient with scleroderma. Korean J Intern Med. 2003;18(4):238-40. PubMed | Google Scholar

  20. Cong L, Xia ZK, Yang RY. Targeting the TGF-βreceptor with kinase inhibitors for scleroderma therapy. Arch Pharm (Weinheim). 2014;347(9):609-615. PubMed | Google Scholar